BCS_Blog_DTOP_BelowTitle_336x280

Experimental Drug Shows Promising Results

A new experimental drug has the potential to change the way advanced breast cancer is treated. It blocks the progression of ER positive breast cancer, which makes up about 60% of breast cancers, by targeting molecules involved in cell division. Patients who took the drug during trials doubled the amount of time they lived without the cancer getting worse — extending this time, on average, by 10 months. Because of the unique nature of the drug, it could also have an impact on other cancers as well, such as pancreatic and lung cancers.

CBS This Morning speaks with Dr. David Agus about this new drug, and when it could potentially be approved by the FDA. Take a look.

Lockerdome BCS – desktop
Medianet BCS
The Breast Cancer Site is a place where supporters and survivors come together to help fight breast cancer. In addition to sharing personal stories of hope, shopping for the cause, and signing petitions, visitors can take just a moment each day to click on a pink button to provide free mammograms for women in need. Visit The Breast Cancer Site and click today - it's free!